For cancer screening to be successful, it should primarily detect cancers with lethal potential
or their precursors early, leading to therapy that reduces mortality and morbidity. Screening …

In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …

Lung cancer is the leading cause of cancer-related death and the second most diagnosed
cancer for both men and women in the United States 1, 2 More than 25, 000 surgeries for …

Innovations in CT have been impressive among imaging and medical technologies in both
the hardware and software domain. The range and speed of CT scanning improved from the …

Simple Summary With the advancement of artificial intelligence, including machine learning,
the field of oncology has seen promising results in cancer detection and classification …

Lung cancer is the leading cause of all cancer deaths worldwide, comprising 18.4% of all
cancer deaths. Low-dose computed tomography (LDCT) has shown mortality benefit in …

Lung cancer is the leading worldwide cause of cancer mortality, as it is often detected at an
advanced stage. Since 2011, low-dose CT scan–based screening has promised a 20 …

Background Machine learning (ML) has emerged as a superior method for the analysis of
large datasets. Application of ML is often hindered by incompleteness of the data which is …

Background Optimal uptake rates of low-dose computed tomography (LDCT) scans are
essential for lung cancer screening (LCS) to confer mortality benefits. We aimed to outline …

Background Glutathione peroxidase-1 (GPX1) is a member of the GPX family, which
considered an enzyme that interacts with oxidative stress. GPX1 differential expression is …